标题
Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-04
DOI
10.1038/s41598-022-15209-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
- (2022) Fangyue Chen et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer
- (2022) Xin Zhang et al. Journal of Immunology Research
- ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
- (2021) Jiali Cai et al. Cell Death & Disease
- The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial–mesenchymal transition
- (2021) Yaoyao Xiong et al. Cancer Cell International
- Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer
- (2021) Jiaming Wan et al. Frontiers in Oncology
- Progress and challenges of immunotherapy in triple-negative breast cancer
- (2021) Yinxing Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
- (2021) Zirui Zhao et al. Journal of Oncology
- HIF-1α (Hypoxia-Inducible Factor-1α) Promotes Macrophage Necroptosis by Regulating miR-210 and miR-383
- (2020) Ela Karshovska et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
- (2020) Shouping Xu et al. Cancer Immunology Research
- Expression analysis of vimentin and the related lncRNA network in breast cancer
- (2020) Mehdi Mohebi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
- (2020) Rong Tang et al. Journal of Hematology & Oncology
- lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer
- (2020) Jin‑Gui Sun et al. Molecular Medicine Reports
- Gene regulation by long non-coding RNAs and its biological functions
- (2020) Luisa Statello et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis-Mediated Innate Immune Response
- (2020) Weiwei Fu et al. Journal of Immunology Research
- Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
- (2019) Peng Guo et al. Science Advances
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor
- (2019) Yuting Chang et al. Cancer Medicine
- An independently validated survival nomogram for lower-grade glioma
- (2019) Haley Gittleman et al. NEURO-ONCOLOGY
- Immune Checkpoint Blockade Mediated by a Small‐Molecule Nanoinhibitor Targeting the PD‐1/PD‐L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer
- (2019) Rui Zhang et al. Small
- B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
- (2019) Johannes Griss et al. Nature Communications
- Low-dose anti-angiogenic therapy sensitizes breast cancer to PD-1 blockade
- (2019) Qian Li et al. CLINICAL CANCER RESEARCH
- Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
- (2018) Si-si Wang et al. Cellular & Molecular Immunology
- Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT
- (2018) Hajar Rezanejad bardaji et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- RIP kinases as modulators of inflammation and immunity
- (2018) Sudan He et al. NATURE IMMUNOLOGY
- B cell and B cell-related pathways for novel cancer treatments
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- A flexible R package for nonnegative matrix factorization
- (2010) Renaud Gaujoux et al. BMC BIOINFORMATICS
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started